Extracorporeal Life Support in Infarct-Related Cardiogenic Shock – Still Valid?

cardiogenic shock ECLS
Cardiogenic shock is the leading cause of death amongst patients hospitalized with acute myocardial infarction. Immediate revascularization of the culprit lesion is the only treatment available but mortality still remains high. The use of extracorporeal life support (ECLS), which enables full circulatory and respiratory support, have increased with the aim to achieve haemodynamic stabilization in patients with severe or rapidly deteriorating infarct-related cardiogenic shock. 

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: